Related Experiment Video
Updated: May 29, 2026

Rapid In Vitro Cytotoxicity Evaluation of Jurkat Expressing Chimeric Antigen Receptor using Fluorescent Imaging
Published on: October 27, 2023
[Apoptosis-inducing effect of C-MYC siRNA on acute lymphoblastic leukemia Jurkat cell line]
Ting-Bo Liu1, Xiao-Feng Luo, Jian-Da Hu
1Fujian Institut of Hematology, Fujian Medical University Union Hospital, Fujian Province, China. liutb@medmail.com.cn
Abstract:
The study was purposed to investigate the effects of C-MYC siRNA on the proliferation and apoptosis of acute lymphoblastic Jurkat cell line. siRNA targeting the site 1545-1565 of C-MYC mRNA was designed and chemically synthesized, then C-MYC siRNA was transfected into Jurkat cells by the transfer agent (HiPerFect Transfection Reagent), the morphological changes were observed under inverted microscope; the tetrazole compound (MTS) was applied to draw the cell growth curve; the cell colony test was used to detect the effect of C-MYC siRNA on the proliferation of Jurkat cells; the flow cytometry and TUNEL method were used to analyze the apoptosis of Jurkat cells. The results showed that after Jurkat cells were treated with different concentrations of C-MYC siRNA, the growth of Jurkat cells was inhibited to various degrees, inhibitory rate was enhanced as C-MYC siRNA concentration increased. C-MYC siRNA also could obviously inhibit the cell clony formation. The apoptosis of cells could be detected by flow cytometry and TUNEL method, the apoptosis rate of cells increased along with prolonging of treatment with C-MYC siRNA. It is concluded that the chemically synthesized C-MYC siRNA can inhibit significantly the proliferation and induce the apoptosis of Jurkat cells.
Insights
Chemically synthesized C-MYC siRNA significantly inhibits acute lymphoblastic Jurkat cell proliferation and induces apoptosis. This targeted approach offers potential for controlling cancer cell growth.
Area of Science:
- Molecular Biology
- Cell Biology
- Cancer Research
Context:
- Acute lymphoblastic leukemia (ALL) is a significant hematological malignancy.
- The c-MYC oncogene plays a crucial role in cell proliferation and apoptosis.
- Targeting c-MYC offers a potential therapeutic strategy for ALL.
Purpose:
- To investigate the effects of C-MYC siRNA on the proliferation and apoptosis of the Jurkat cell line.
- To assess the efficacy of chemically synthesized C-MYC siRNA in inhibiting cancer cell growth.
- To analyze the impact of C-MYC siRNA on Jurkat cell apoptosis.
Summary:
- C-MYC siRNA was designed, synthesized, and transfected into Jurkat cells.
- Cell proliferation was assessed using MTS assays and colony formation tests.
- Apoptosis was evaluated via flow cytometry and TUNEL assays.
- Results demonstrated dose-dependent inhibition of proliferation and increased apoptosis with C-MYC siRNA treatment.
Impact:
- C-MYC siRNA effectively inhibits Jurkat cell proliferation.
- C-MYC siRNA induces significant apoptosis in Jurkat cells.
- This study validates C-MYC siRNA as a potential therapeutic agent for acute lymphoblastic leukemia.
Related Concept Videos
The Intrinsic Apoptotic Pathway
Induced Pluripotent Stem Cells
Somatic cells are...
Abnormal Proliferation
Inhibition of Cdk Activity
